English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jul 14, 2026

Review highlights cell death network as key driver in acute respiratory distress syndrome
+ Pharmaceuticals
Patient Daily | Jul 14, 2026

Review from Kansas City University examines astrocytes' role in chronic traumatic encephalopathy
+ Pharmaceuticals
Patient Daily | Jul 14, 2026

Study finds mitochondrial DNA mutations linked to cardiometabolic parameters in metabolic syndrome
+ Pharmaceuticals
Patient Daily | Jul 14, 2026

FDA approves starter dose of subcutaneous Leqembi for Alzheimer’s treatment
+ Pharmaceuticals
Patient Daily | Jul 14, 2026

Biogen advances tau-targeting Alzheimer’s therapy to Phase 3 after mid-stage trial results
Patient Daily | Jul 13, 2026

Society of Cardiovascular CT introduces new president and leadership team for 2026-2027
+ Regulatory
A. J. Ali | Jul 13, 2026

Patients Come First on 340B: 'Pushing patients to the brink of financial ruin'
+ Pharmaceuticals
Patient Daily | Jul 13, 2026

High physician knowledge scores linked to lower healthcare costs

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation